[
  {
    "ts": null,
    "headline": "3 things this healthcare exec is aligned with the Trump admin. on",
    "summary": "Cardinal Health (CAH)CFO Aaron Alt sits down with Julie Hyman to speak more about the Trump administration's healthcare policies, especially as the Affordable Care Act (ACA, also known as Obamacare) subsidies expired at the end of 2025. Also catch Aaron Alt discuss the trends in healthcare demands as the American patient population continues to age. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finnhub.io/api/news?id=1c31dbb47902218594dee3e464def1e5538f01849e2eb4370269789c549485f5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770490853,
      "headline": "3 things this healthcare exec is aligned with the Trump admin. on",
      "id": 138387510,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Cardinal Health (CAH)CFO Aaron Alt sits down with Julie Hyman to speak more about the Trump administration's healthcare policies, especially as the Affordable Care Act (ACA, also known as Obamacare) subsidies expired at the end of 2025. Also catch Aaron Alt discuss the trends in healthcare demands as the American patient population continues to age. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
      "url": "https://finnhub.io/api/news?id=1c31dbb47902218594dee3e464def1e5538f01849e2eb4370269789c549485f5"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health price target raised to $255 from $245 at Morgan Stanley",
    "summary": "Morgan Stanley raised the firm’s price target on Cardinal Health (CAH) to $255 from $245 and keeps an Overweight rating on the shares. The risk reward for Cardinal Health has been updated following the company’s “strong” Q2 results, the analyst tells investors in a research note.Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Pu",
    "url": "https://finnhub.io/api/news?id=070c1928194c7efbbcb28d22579dd179a2d2c169becdb9d6fff02ffceea48d94",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770479131,
      "headline": "Cardinal Health price target raised to $255 from $245 at Morgan Stanley",
      "id": 138385788,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "Morgan Stanley raised the firm’s price target on Cardinal Health (CAH) to $255 from $245 and keeps an Overweight rating on the shares. The risk reward for Cardinal Health has been updated following the company’s “strong” Q2 results, the analyst tells investors in a research note.Claim 50% Off TipRanks PremiumUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Pu",
      "url": "https://finnhub.io/api/news?id=070c1928194c7efbbcb28d22579dd179a2d2c169becdb9d6fff02ffceea48d94"
    }
  },
  {
    "ts": null,
    "headline": "Cardinal Health Q2 2026 Review: An Epitome Of Resilience And Earnings Power (Upgrade)",
    "summary": "Cardinal Health (CAH) upgraded to Buy after strong Q2 FY2026 results, higher guidance, and $750M buybacks. Read here for more analysis.",
    "url": "https://finnhub.io/api/news?id=ba8a5eb56f9481dc20f5c92730b08eab676225d1b0be2f332286e8bf445afc62",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770423644,
      "headline": "Cardinal Health Q2 2026 Review: An Epitome Of Resilience And Earnings Power (Upgrade)",
      "id": 138382578,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1424217301/image_1424217301.jpg?io=getty-c-w1536",
      "related": "CAH",
      "source": "SeekingAlpha",
      "summary": "Cardinal Health (CAH) upgraded to Buy after strong Q2 FY2026 results, higher guidance, and $750M buybacks. Read here for more analysis.",
      "url": "https://finnhub.io/api/news?id=ba8a5eb56f9481dc20f5c92730b08eab676225d1b0be2f332286e8bf445afc62"
    }
  }
]